Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.49 |
| ▸ | BCL2 | P10415 | 1/20 | 0.49 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.46 |
| ▸ | KMO | O15229 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7365145 | 0.83 | ALDH1A1 (0.65) | AGXTGPR84AOC3GGPS1FFAR1 | |
| SCHEMBL1262278 | 0.82 | AGXT (0.55) | AGXTGPR84BCL2NR4A2AOC3 | |
| SCHEMBL5539870 | 0.79 | FFAR1 (0.59) | AGXTFFAR1 | |
| SCHEMBL4533749 | 0.78 | AGXT (0.52) | AGXTGPR84BCL2AOC3GGPS1 | |
| SCHEMBL29618101 | 0.78 | SIGMAR1 (0.52) | AGXT | |
| SCHEMBL5544652 | 0.78 | AGXT (0.57) | AGXTGPR84BCL2NR4A2AOC3 | |
| SCHEMBL5865105 | 0.78 | TDP1 (0.62) | AGXTGPR84BCL2ACMSDAOC3 | |
| SCHEMBL5483210 | 0.78 | AGXT (0.52) | AGXTGPR84BCL2AOC3GGPS1 | |
| SCHEMBL11358683 | 0.78 | TDP1 (0.62) | AGXTGPR84BCL2AOC3GGPS1 | |
| SCHEMBL28269703 | 0.78 | AGXT (0.52) | AGXTGPR84BCL2AOC3GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7125999-B2 | Process for producing organotitanium compound and process for addition reaction | NISSAN CHEMICAL INDUSTIES, LTD. (JP) | 2006-10-24 | — | — | US | disclosed |
| US-20040167344-A1 | Process for producing organotitanium compound and process for addition reaction | FUMIE SATO | 2004-08-26 | — | — | US | disclosed |
| US-6743916-B2 | REACTING AN ACETYLENE COMPOUND IN THE PRESENCE OF A TITANIUM COMPOUND AND GRIGNARD REAGENT TO OBTAIN ORGANOTITANIUM COMPOUND | Sato, Fumie (JP) | 2004-06-01 | — | — | US | disclosed |
| US-20030096996-A1 | Process for producing organotitanium compound and process for addition reaction | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-05-22 | — | — | US | disclosed |
| EP-1299379-A2 | LACTAM METALLOPROTEASE INHIBITORS | Bristol-Myers Squibb Pharma Company (US) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002004416-A2 | LACTAM METALLOPROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-01-17 | — | — | WO | disclosed |
| EP-1054877-A1 | NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS | Du Pont Pharmaceuticals Company (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999041246-A1 | NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167344-A1 | Process for producing organotitanium compound and process for addition reaction | ZYX, H1-4, GRIA4 | AGXT 122/4885GPR84 2664/4885BCL2 4715/4885 |
| US-20030096996-A1 | Process for producing organotitanium compound and process for addition reaction | ZYX, H1-4, GRIA4 | AGXT 122/4885GPR84 2664/4885BCL2 4715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.